What is the preferred antiepileptic medication for focal (partial) seizures in a typical adult?

Antiepileptic of Choice in Focal Seizure

For newly diagnosed focal (partial) seizures in adults, carbamazepine or oxcarbazepine should be your first-line choice, with levetiracetam as an alternative if there is no psychiatric history. 1

First-Line Monotherapy Options

The evidence strongly supports several medications as equally effective first-line agents for focal epilepsy:

• Carbamazepine: Most cost-effective option and traditional gold standard 2
• Oxcarbazepine: Should be considered alongside carbamazepine; better tolerability profile than carbamazepine 3, 1
• Lamotrigine: Should be considered as first-line (Level B evidence) 1
• Levetiracetam: May be considered if no history of psychiatric disorders 3, 1

Clinical Decision Algorithm

Start with:

1. Carbamazepine or oxcarbazepine - if patient has no cardiac conduction abnormalities, no significant drug interactions, and cost is a consideration
2. Lamotrigine - if patient needs better tolerability or is female of childbearing potential
3. Levetiracetam - if patient needs rapid titration, has no psychiatric history (depression, anxiety, irritability), and drug interactions are a concern

Key Differentiating Factors

Carbamazepine/Oxcarbazepine advantages:

• Proven long-term efficacy
• Most cost-effective 2
• Oxcarbazepine has fewer drug interactions than carbamazepine

Carbamazepine/Oxcarbazepine disadvantages:

• Enzyme-inducing properties cause multiple drug interactions
• Can worsen coronary/cerebrovascular disease through hyperlipidemia 3
• Accelerate osteopenia/osteoporosis development 3
• Require monitoring for hyponatremia (especially oxcarbazepine)

Levetiracetam advantages:

• No drug interactions
• Rapid titration possible
• Can be loaded in emergency situations (1,500 mg oral or IV) 4
• Best tolerability profile for treatment-emergent adverse events 5

Levetiracetam disadvantages:

• Psychiatric side effects (irritability, depression, behavioral changes) in 25-50% of patients with pre-existing psychiatric disorders 3

Lamotrigine advantages:

• Excellent for patients with comorbid mood disorders
• Preferred in women of childbearing potential
• Good long-term tolerability

Lamotrigine disadvantages:

• Requires slow titration (risk of serious rash)
• Cannot be loaded acutely
• Takes weeks to reach therapeutic dose

Additional Effective Options

Other medications with proven efficacy as monotherapy include 1:

• Zonisamide (Level C)
• Lacosamide (FDA-approved for monotherapy)
• Eslicarbazepine (FDA-approved for monotherapy)

Common Pitfalls to Avoid

1. Do not use phenytoin as first-line unless in emergency situations - it has inferior tolerability and significant drug interactions despite being effective 3

2. Avoid enzyme-inducing agents (carbamazepine, phenytoin, phenobarbital) in patients with:

   • Cardiovascular disease
   • Osteoporosis risk
   • Multiple concomitant medications
   • Oral contraceptive use

3. Do not use levetiracetam in patients with:

   • History of depression, anxiety, or behavioral disorders
   • Active psychiatric symptoms

4. Avoid valproate in women of childbearing potential - though effective, it carries significant teratogenic risk

Special Populations

Elderly patients (≥60 years):

• Lamotrigine should be considered (Level B) 1
• Gabapentin may be considered (Level C) 1
• Lower starting doses and slower titration needed

Patients with comorbidities:

• Select based on drug interaction profile and effect on comorbid conditions 3
• Avoid enzyme-inducers if patient takes medications metabolized by cytochrome P450

Emergency Department Context

For patients presenting to the ED with breakthrough seizures on existing therapy, loading strategies differ 4:

• Levetiracetam: 1,500 mg oral or IV load (safe, well-tolerated)
• Phenytoin/Fosphenytoin: 18-20 mg/kg IV (traditional but more adverse effects)
• Lacosamide: IV formulation available (indicated for partial seizures only)

The evidence shows no significant difference in seizure recurrence between oral and IV loading for most medications, though IV achieves therapeutic levels faster 4.